FLNA
NASD Filana Therapeutics, Inc.$0.9314 ↑ +0.0067 (+0.72%) Trading Up from the previous close of $0.9247
- YTD change
- -55.44%
- vs 20-day SMA
- +16.17%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.70 (-42.92%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 81.3% away from all-time highs of $4.9800
- FLNA is down 55% since the beginning of the year
- FLNA is down 55% over the past 12 months
- FLNA is up 4% over the past 1 month
- 14% of all FLNA investors are betting against FLNA
FLNA reads neutral: the 12-month move is -55.8%.
- Previous minute
- +$0.0014
- Last hour
- +$0.0296
- Last 5 days
- -9.57%
- vs 8-day SMA
- +11.81%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.